Our past vaccine studies using the candidate Sm-Cathepsin B induced promising protection levels against schistosomiasis in mice whether formulated with Montanide ISA 720 VG or CpG dinucleotides adjuvants (19, 20). Here, CTSB is linked to schistosomiasis.